Physician profile
Lance E Hardison
NPI 1407084155
$11,912.75
in general payments reported to CMS, 2019-2025
29 companies · $865 in 2025
The $865 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,330 · 2020: $3,810 · 2021: $1,794 · 2022: $1,318 · 2023: $1,358 · 2024: $437 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,670.63 | 2019-2025 | Salvation, Ortholoc 2 Lapifuse, Augment Injectable |
| Arthrex, INC. | $2,473.24 | 2020 | |
| Medical Device Business Services, INC. | $1,062.03 | 2019 | |
| Trice Medical, INC. | $650.45 | 2019-2023 | |
| Orthofix Medical, INC. | $555.17 | 2021-2023 | Truelok, Tl-Hex Truelok Hexapod System, Truelok System |
| Organogenesis INC. | $532.71 | 2019-2022 | |
| Pylant Medical | $490.15 | 2019-2021 | |
| Depuy Synthes Sales INC. | $480.35 | 2019-2025 | Motoband, Na, Dynaforce |
| Treace Medical Concepts, INC. | $436.85 | 2021-2025 | |
| Medline Industries Lp | $233.46 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $205.23 | 2019 | |
| Wright Medical Technology, INC. | $199.31 | 2019 | |
| Smith+Nephew, INC. | $180.46 | 2019-2022 | |
| Restor3d, INC. | $170.16 | 2024-2025 | |
| Bone Support INC. | $165.55 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $151.29 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Angiodynamics, INC. | $147.14 | 2022 | |
| Sanara Medtech INC. | $140.27 | 2021 | |
| Nevro Corp. | $135.47 | 2022 | |
| Amdt Holdings, INC. | $132.95 | 2020 | |
| Boston Scientific Corporation | $131.85 | 2022-2024 | Infinion 16, Wavewriter Alpha Prime 16 |
| Kci USA, INC. | $121.34 | 2020 | |
| Curonix LLC | $104.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Horizon Therapeutics Plc | $102.93 | 2022-2023 | Krystexxa |
| Anika Therapeutics, INC. | $95.06 | 2022 | |
| Convatec INC. | $74.96 | 2023 | |
| Ossio INC | $33.27 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.50 | 2023 | Jublia |
| Paratek Pharmaceuticals, INC. | $16.01 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Hardison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.